Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 612
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT04660799 A Study on Pharmacokinetics (PK), Efficacy and Safety of Subcutaneous (… |
Rituximab IV | SEP | Phase 2 | COMPLETED | En attente / non publié | Hoffmann-La Roche | China · Fujian Provincial Cancer Hospital, Fuzhou, Ch… | 2021-02-24 → 2022-10-11 | Ouvrir |
| NCT00244985 Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed … |
Rituximab | SEP | Phase 1/2 | COMPLETED | En attente / non publié | National Cancer Institute (NCI) | United States · Roswell Park Cancer Institute, Buffal… | 2005-09 → 2012-12 | Ouvrir |
| NCT00244855 Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hod… |
Rituximab | SEP | Phase 2 | COMPLETED | En attente / non publié | National Cancer Institute (NCI) | United States · Fred Hutchinson Cancer Research Cente… | 2004-05 → 2011-08-29 | Ouvrir |
| NCT05878184 Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT) |
SC291 | SEP | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Sana Biotechnology | United States, Australia · City of Hope, Duarte, Unit… | 2023-05-02 → 2038-11-04 | Ouvrir |
| NCT02992834 Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for C… |
IL-2 pre-treated CD19 cells | SEP | Phase 4 | UNKNOWN | En attente / non publié | jiangjingting | China · First People's Hospital of Changzhou, Changzh… | 2016-12 → 2022-01 | Ouvrir |
| NCT07367685 Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatmen… |
QH103 Cell Injection | SEP | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | The Second Affiliated Hospital of… | China · The Second Affiliated Hospital of Fujian Medi… | 2026-05-01 → 2028-12-31 | Ouvrir |
| NCT04806347 Alpha/Beta T-cell Depleted Blood-forming Stem Cell Transplant From Rela… |
TCRαβ+/CD19+ depleted Hematopoiet… | SEP | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | University of Wisconsin, Madison | Non communiqué | 2026-09 → 2030-06 | Ouvrir |
| NCT02143414 Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and… |
Biopsy Procedure | SEP | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · Ascension Via Christi Hospitals Wichi… | 2015-06-30 → 2027-06-06 | Ouvrir |
| NCT02427776 SCLEROLYM — A Trial for Evaluating Both Safety and Preliminary Efficacy… |
Autologous CD4+T cells stimulated… | SEP | Phase 1/2 | TERMINATED | En attente / non publié | Imcyse SA | Belgium · Cliniques universitaires Saint-Luc, Brussel… | 2015-01 → 2016-08 | Ouvrir |
| NCT01895439 Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cel… |
Autologous Mesenchymal Stem Cells | SEP | Phase 1/2 | COMPLETED | En attente / non publié | University of Jordan | Jordan · Cell Therapy Center, Jordan University Hospi… | 2012-10 → 2016-02 | Ouvrir |
| NCT05893225 Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain… |
Metformin Hydrochloride 850 mg Or… | SEP | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | University Hospital, Antwerp | Belgium · Antwerp University Hospital, Edegem, Belgiu… | 2023-11-23 → 2027-02-28 | Ouvrir |
| NCT07304024 CAPD-LOOT — A Treatment for a Form of Age-Related Central Auditory Proc… |
Clemastine Fumarate Combined With… | SEP | Phase 1/2 | RECRUITING | En attente / non publié | University of Colorado, Denver | United States · University of Colorado Anschutz Medic… | 2025-03-31 → 2028-07 | Ouvrir |
| NCT06330077 MODIF-MS — Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sc… |
Ifenprodil | SEP | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Assistance Publique - Hôpitaux de… | France · Groupe Hospitalier Pitié Salpêtrière - APHP,… | 2024-03 → 2027-06 | Ouvrir |
| NCT01451593 Neuroprotection With Phenytoin in Optic Neuritis |
Phenytoin | SEP | Phase 2 | COMPLETED | En attente / non publié | University College, London | United Kingdom · National Hospital For Neurology and … | 2011-11 → 2015-03 | Ouvrir |
| NCT03562975 Upper Extremity Function in Multiple Sclerosis Patients With Advanced D… |
Ocrelizumab | SEP | À vérifier | COMPLETED | En attente / non publié | Hoffmann-La Roche | United States · Carol and Frank Morsani Center for Ad… | 2018-07-23 → 2023-01-11 | Ouvrir |
| NCT06847724 Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocr… |
CYB704 | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Sandoz | United States, Bosnia and Herzegovina, Bulgaria, Croa… | 2025-06-10 → 2027-05 | Ouvrir |
| NCT06220669 A Study of LY3541860 in Adult Participants With Relapsing Multiple Scle… |
LY3541860 | SEP | Phase 2 | TERMINATED | En attente / non publié | Eli Lilly and Company | United States, France, Italy, Latvia, Poland, Slovaki… | 2024-03-19 → 2026-07-13 | Ouvrir |
| NCT03958877 A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (… |
BIIB017 (peginterferon beta-1a) | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Biogen | United States, Argentina, Australia, Belgium, Bulgari… | 2019-10-18 → 2027-05-20 | Ouvrir |
| NCT07842302 NIBS_MSf — Fighting Fatigue in Multiple Sclerosis: TMS vs. tDCS Efficac… |
TMS | SEP | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Universitat Oberta de Catalunya | Non communiqué | 2026-09 → 2029-09 | Ouvrir |
| NCT03822858 Expanded Access to Intrathecal Administration of Autologous Mesenchymal… |
Intrathecal MSC-NP injection | SEP | À vérifier | NO_LONGER_AVAILABLE | En attente / non publié | Tisch Multiple Sclerosis Research… | United States · Tisch MS Research Center of New York,… | Non communiqué | Ouvrir |
| NCT07840924 The CanISleepinMS Study: Effect of Cannabidiol (CBD) on Sleep Quality i… |
Cannabidiol Oil | SEP | Phase 2 | COMPLETED | En attente / non publié | Wageningen University | Netherlands · Rijnstate, Arnhem, Netherlands | 2024-03-26 → 2026-03-28 | Ouvrir |
| NCT07840326 A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary P… |
SUN-627 | SEP | Phase 2 | RECRUITING | En attente / non publié | Sundance Biosciences, Inc. | United States · Local Institution - Site 101, Raleigh… | 2026-10 → 2027-07 | Ouvrir |
| NCT05835622 EXHOMESEP — Clinical Investigation of the Quality of Life Benefit of Us… |
Keeogo | SEP | Non applicable | COMPLETED | En attente / non publié | Pôle Saint Hélier | France · Centre de rééducation Fonctionnelle Propara-… | 2024-02-01 → 2026-09-18 | Ouvrir |
| NCT07299019 A Study of Orelabrutinib in Patients With Secondary Progressive Multipl… |
Orelabrutinib | SEP | Phase 3 | RECRUITING | En attente / non publié | Zenas BioPharma (USA), LLC | United States, Bulgaria, Croatia, Czechia, Estonia, G… | 2026-03-23 → 2030-07 | Ouvrir |
| NCT05119569 FENopta — A Study to Investigate the Efficacy of Fenebrutinib in Relaps… |
Fenebrutinib | SEP | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Bosnia and Herzegovina, Croatia, Czech… | 2022-03-01 → 2027-06-30 | Ouvrir |